Literature DB >> 7426157

Excessive plasma dopamine increase at rest and during exercise after long-term beta-adrenoreceptor blockade in hypertensive patients.

I W Franz, F W Lohmann, G Koch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7426157      PMCID： PMC482355          DOI： 10.1136/hrt.44.1.25

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  13 in total

1.  Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.

Authors:  G Koch
Journal:  Br Heart J       Date:  1979-02

2.  [Dopamine in treatment of acute severe heart insufficiency].

Authors:  B Ramdohr; G Biamino; K P Schŭren; R Schrŏder
Journal:  Med Welt       Date:  1975-03-21

3.  [The effect of so-called cardioselective and non-cardioselective beta-receptor blockers on the metabolism during ergometric exercise in hypertensive patients].

Authors:  I W Franz; F W Lohmann; G Koch; L Röcker
Journal:  Verh Dtsch Ges Inn Med       Date:  1978

4.  [Specific and non-specific effects of beta-adreno-receptor blocking drugs in man (author's transl)].

Authors:  H Grobecker; G Planz; G Wiethold; R Simrock; H J Becker; E Lutz; P Petersen
Journal:  Klin Wochenschr       Date:  1976-08-15

Review 5.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

6.  Direct effects of dopamine, orciprenaline and norepinephrine on the right and left ventricle of isolated canine hearts.

Authors:  H D Schmidt; H Hoppe; L Heidenreich
Journal:  Cardiology       Date:  1979       Impact factor: 1.869

7.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

8.  Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.

Authors:  H Galbo; J J Holst; N J Christensen; J Hilsted
Journal:  J Appl Physiol       Date:  1976-06       Impact factor: 3.531

9.  Effects of beta adrenergic blockade on plasma catecholamines in exercise.

Authors:  M H Irving; B J Britton; W G Wood; C Padgham; M Carruthers
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

10.  [Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].

Authors:  R Kolloch; K O Stumpe; M Higuchi; H Vetter; F Krück
Journal:  Klin Wochenschr       Date:  1977-10-15
View more
  8 in total

Review 1.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

2.  [Differential effect of long-term beta1-selective and nonselective beta-receptor blockade on carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].

Authors:  I W Franz; F W Lohmann
Journal:  Klin Wochenschr       Date:  1980-10-15

3.  [Effect of a beta 1-receptor blocker on the plasma level of atrial natriuretic peptide in patients with essential hypertension in the exercise test].

Authors:  J Plum; M Hollenbeck; P Heering; B Grabensee
Journal:  Klin Wochenschr       Date:  1990-05-04

4.  Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.

Authors:  I W Franz; B Agrawal; D Wiewel; R Ketelhut
Journal:  Clin Investig       Date:  1992

5.  Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.

Authors:  K Eliasson; T Kahan; B Hylander; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

6.  Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; C Smith; D J Betteridge; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

7.  Effect of chronic beta-adrenergic blockade on exercise-induced leukocytosis.

Authors:  L Röcker; I W Franz
Journal:  Klin Wochenschr       Date:  1986-03-17

Review 8.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.